David Fredrickson
EVP, Oncology Business UnitAstraZeneca
PharmaceuticalsView Profile →President, Head of Europe · Biogen
Wolfram Schmidt is Biogen’s president and head of Europe, with earlier pharmaceutical leadership at Roche, MSD and Boehringer Ingelheim.
Last reviewed: Nov 2, 2026
President, Head of Europe
Biogen
Last Reviewed: November 2, 2026
Wolfram Schmidt is Biogen’s president and head of Europe, with earlier pharmaceutical leadership at Roche, MSD and Boehringer Ingelheim.
Schmidt trained in chemistry at Ulm University and the University of Bayreuth. His pharmaceutical career included leadership positions at Boehringer Ingelheim, Merck Sharp & Dohme and Roche, with work in both the United States and Europe.
He joined Biogen in 2018 as managing director of Biogen Germany, the company’s largest subsidiary outside the United States. By 2022, Biogen identified him as president for Europe, Canada and Partner Markets in its European corporate materials.
Schmidt now serves as president and head of Europe and belongs to Biogen’s extended leadership team. Alongside his company responsibilities, he is a board member of the European Federation of Pharmaceutical Industries and Associations.
His earlier industry association work included the presidency of American Biotechnology Companies Germany and executive board service at Germany’s Association of Research-Based Pharmaceutical Companies. He also sits on the supervisory board of a:head, an Austrian neuroscience company working with stem cells and brain organoids.
Schmidt holds a master’s degree in chemistry from Ulm University and a Ph.D. in chemistry from the University of Bayreuth.